Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Clinically Relevant Drug Product Specifications: Methods of Establishment

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Good Manufacturing Practices

Good Manufacturing Practices

Good Manufacturing Practices (GMP) constitute a foundational set of guidelines that ensure the production of safe, consistent, and high-quality products, particularly in industries such as pharmaceuticals, biotechnology, and food processing. These protocols encompass all aspects of production, from the sourcing of raw materials to the final distribution of the finished product.A core pillar of GMP is stringent hygiene and sanitation across all production environments. This includes routine...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Selectins in Biology and Human Disease: Opportunity in E-selectin Antagonism.

Cureus·2024

Same author

Real-world outcomes of 18,186 metastatic solid tumor outpatients: Baseline blood cell counts correlate with survival after immune checkpoint inhibitor therapy.

Cancer medicine·2023

Same author

Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis.

Frontiers in immunology·2023

Same author

Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders.

Frontiers in immunology·2023

Same author

Adverse Drug Reaction vs Care Complication: Response to "Use of Colony-Stimulating Factors in Patients With Systemic Lupus Erythematous".

Journal of pharmacy practice·2023

Same author

Role of Fcγ receptors in HER2-targeted breast cancer therapy.

Journal for immunotherapy of cancer·2022

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

GCP data quality for early clinical development.

Edwin P Rock¹, Vernette J Molloy, Jeffrey S Humphrey

¹Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, New Jersey, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

|March 11, 2010

Summary

This summary is machine-generated.

Good Clinical Practice (GCP) ensures clinical trial subject safety and data quality. Investigators can adopt GCP data integrity practices to prevent adverse audit findings during regulatory inspections.

More Related Videos

Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants

Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

Related Experiment Videos

Last Updated: Jun 15, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants

Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

Area of Science:

Clinical research
Regulatory affairs
Medical ethics

Background:

Good Clinical Practice (GCP) is an international standard for clinical trial conduct.
GCP ensures participant safety and data integrity, drawing from ethical principles in the Declaration of Helsinki.
Data quality provisions in GCP evolved from U.S. Food and Drug Administration (FDA) regulations addressing data fraud in the 1960s.

Purpose of the Study:

To summarize Good Clinical Practice (GCP) data quality provisions.
To outline practical measures for clinical site investigators to ensure GCP compliance.
To guide investigators in preventing negative findings during regulatory inspections.

Main Methods:

Review of Good Clinical Practice (GCP) guidelines and historical regulatory evolution.
Analysis of ethical principles from the Declaration of Helsinki.
Identification of investigator practices for data integrity and regulatory compliance.

Main Results:

GCP mandates rigorous standards for subject safety and data quality in clinical trials.
Historical context reveals GCP data quality principles stem from the need to combat data fraud.
Specific investigator practices can ensure adherence to GCP data integrity requirements.

Conclusions:

Adherence to GCP data quality provisions is crucial for reliable clinical trial outcomes.
Implementing recommended practices helps investigators maintain compliance and avoid audit issues.
GCP serves as a vital framework for ethical and scientifically sound clinical research.